This has been a pain...but...on I-17 it says:

"Observe the page number limitations given in Table 2.6-1...The page number limitations may also be different for other specialized grant applications (e.g., R03 and R21 applications). Consult and follow the additional instructions for those applications."

Indeed, all the R21 PAs I have seen do mention the one page in the "Other Submission Requirements".

Take home message: PA instructions trump the SF424 guide.

CH

At 12:32 PM 6/28/2006, you wrote:
>Another issue for the revised R21:
>
>We just submitted a revised R21 and it bounced back with an error
>stating that the introduction can not be more than 1 PAGE. This is
>incorrect. As far as I know, the PI still has 3 pages for their intro.
>The SF 424 R&R Application Guide also confirms the three page limit
>(page I-18). I sent an e-mail to the help desk regarding this issue. Has
>any one else received this error?
>
>Best,
>
>
>Regeane Villarson, MBA
>Assistant Manager
>Office of Research and Sponsored Programs
>New Jersey Medical School
>973-972-8649
>972-972-3585 (fax)
>
>>>> xxxxxx@LHS.ORG 06/28/06 12:03 PM >>>
>We have an investigator resubmitting an R21 for July 1 who has raised
>an
>interesting question regarding the Introduction in the SF424RR.  She
>and
>others in the past have typically referenced page numbers in the
>Research
>Plan to note some changes or revisions.  Since page numbers are now
>not
>allowed, any suggestions as to how to handle this?
>
>Thanks in advance.  The collective talent and wisdom on this LISTSERV
>is
>greatly appreciated.
>
>Regards,
>Steve Hunter
>Legacy Research
>Portland, Oregon
>
>
>
>
>IMPORTANT NOTICE:  This communication, including any attachment,
>contains
>information that may be confidential or privileged, and is intended
>solely
>for the entity or individual to whom it is addressed.  If you are not
>the
>intended recipient, you should contact the sender and delete the
>message.
>Any unauthorized disclosure, copying, or distribution of this message
>is
>strictly prohibited.  Nothing in this email, including any attachment,
>is
>intended to be a legally binding signature.
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================